IDH-wild-type and IDH mutant 1p-19q co-deleted glioma cases did not change dramatically in terms of their epigenomic profiles, but, among the IDH mutant non-Codel gliomas, we defined distinct patterns of epigenetic shifts throughout the course of tumor recurrence. The gene discussed is IDH2; the disease is central nervous system cancer.